U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C13H24N4O3S.C4H4O4
Molecular Weight 432.492
Optical Activity ( + )
Defined Stereocenters 1 / 1
E/Z Centers 1
Charge 0

SHOW SMILES / InChI
Structure of TIMOLOL MALEATE, (R)-

SMILES

OC(=O)\C=C/C(O)=O.CC(C)(C)NC[C@@H](O)COC1=NSN=C1N2CCOCC2

InChI

InChIKey=WLRMANUAADYWEA-ASSQPYIHSA-N
InChI=1S/C13H24N4O3S.C4H4O4/c1-13(2,3)14-8-10(18)9-20-12-11(15-21-16-12)17-4-6-19-7-5-17;5-3(6)1-2-4(7)8/h10,14,18H,4-9H2,1-3H3;1-2H,(H,5,6)(H,7,8)/b;2-1-/t10-;/m1./s1

HIDE SMILES / InChI

Description
Curator's Comment: The description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/8286 | https://www.ncbi.nlm.nih.gov/pubmed/2896241

(R)-Timolol is the (R)-enantiomer of non-selective Beta antagonist Timolol. (R)-Timolol is a ß-adrenergic blocking agent that binds only to nonspecific sites in the particulate fraction of the heart, lungs, and brain. (R)-Timolol is an antihypertensive agent that increases ocular blood flow and reduces intraocular pressure. (R)-Timolol is one of the impurities in commercial formulation of (S)-Timolol.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
26.9 nM [Kd]
13.8 nM [Kd]
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Stereospecific binding of timolol, a beta-adrenergic blocking agent.
1976 Jul-Aug
Patents

Patents

Sample Use Guides

In Vivo Use Guide
Rats were treated i.v. with 0.1 mg/kg of (R)-Timolol Rats were treated p.o. with 1-10mg/kg of (R)-Timolol
Route of Administration: Other
In Vitro Use Guide
Rabbit eyes and heart ventricle were from New Zealand albino males, 3 to 6 months old. Chary process villae were separated carefully from any contaminating iris or ciliary body, washed once in 150 mM NaCl and homogenized (10 mg/ml) by hand in an all-glass homogenizer in 6 mM Tris maleate buffer, pH 7.4. Heart tissue was first minced and then homogenized (20-50 mg/ml). Aparticulate (P1) preparation was prepared by diluting the homogenate in 20 volumes of 6 mM Tris maleate buffer, centrifuging at 100,000 x g for 30 min, and resuspending the pellet in the initial volume of buffer used for homogenization. Kinetic constants obtained using the P1 fraction as a source of adenylate cyclase were similar to those obtained using homogenates. Inhibition (by various concentrations of an antagonist) of beta adrenergic receptor-mediated activation of adenylate cyclase activity was used to determine the inhibitory constants. IC50 values were determined utilizing 12 to 16 data points per dose-response curve. For the inhibition curves, various concentrations of antagonist were tested against a fixed concentration of (-)-isoproterenol. Stimulation in the presence of isoproterenol plus antagonist was calculated as the increase over that seen in the presence of antagonist alone.
Name Type Language
TIMOLOL MALEATE, (R)-
Common Name English
(R)-(+)-3-MORPHOLINO-4-(3-TERT-BUTYLAMINO-2-HYDROXYPROPOXY)-1,2,5-THIADIAZOLE HYDROGEN MALEATE
Systematic Name English
(R)-TIMOLOL HYDROGEN MALEATE
Common Name English
J369.187J
Code English
2-PROPANOL, 1-(TERT-BUTYLAMINO)-3-((4-MORPHOLINO-1,2,5-THIADIAZOL-3-YL)OXY)-, (+)-, MALEATE (1:1) (SALT), (-)-
Common Name English
(2R)-1-((1,1-DIMETHYLETHYL)AMINO)-3-((4-(4-MORPHOLINYL)-1,2,5-THIADIAZOL-3-YL)OXY)-2-PROPANOL (2Z)-2-BUTENEDIOATE SALT
Systematic Name English
TIMOLOL MALEATE, (+)-
Common Name English
(+)-TIMOLOL MALEATE
Common Name English
(2R)-1-((2-METHYL-2-PROPANYL)AMINO)-3-((4-(4-MORPHOLINYL)-1,2,5-THIADIAZOL-3-YL)OXY)-2-PROPANOL (2Z)-2-BUTENEDIOATE (1:1)
Systematic Name English
Timolol maleate, r-enantiomer [WHO-DD]
Common Name English
(+)-3-(3-(TERT-BUTYLAMINO)-2-HYDROXYPROPOXY)-4-MORPHOLINO-1,2,5-THIADIAZOLE MALEATE
Systematic Name English
(Z)-BUT-2-ENEDIOIC ACID, (2R)-1-(TERT-BUTYLAMINO)-3-((4-MORPHOLIN-4-YL-1,2,5-THIADIAZOL-3-YL)OXY)PROPAN-2-OL
Systematic Name English
(R)-(+)-TIMOLOL MALEATE
Common Name English
(+)-3-(3-TERT-BUTYLAMINO-2-HYDROXYPROPOXY)-4-MORPHOLINO-1,2,5-THIADIAZOLE HYDROGEN MALEATE
Systematic Name English
TIMOLOL MALEATE, R-ENANTIOMER
WHO-DD  
Common Name English
TIMOLOL RELATED COMPOUND A [USP-RS]
Common Name English
D-TIMOLOL MALEATE
Common Name English
2-PROPANOL, 1-((1,1-DIMETHYLETHYL)AMINO)-3-((4-(4-MORPHOLINYL)-1,2,5-THIADIAZOL-3-YL)OXY)-, (2R)-, (2Z)-2-BUTENEDIOATE (1:1)
Systematic Name English
Code System Code Type Description
SMS_ID
100000084608
Created by admin on Sat Dec 16 09:05:09 GMT 2023 , Edited by admin on Sat Dec 16 09:05:09 GMT 2023
PRIMARY
CAS
26839-77-0
Created by admin on Sat Dec 16 09:05:09 GMT 2023 , Edited by admin on Sat Dec 16 09:05:09 GMT 2023
PRIMARY
PUBCHEM
5702122
Created by admin on Sat Dec 16 09:05:09 GMT 2023 , Edited by admin on Sat Dec 16 09:05:09 GMT 2023
PRIMARY
FDA UNII
78U14B243Y
Created by admin on Sat Dec 16 09:05:09 GMT 2023 , Edited by admin on Sat Dec 16 09:05:09 GMT 2023
PRIMARY
ECHA (EC/EINECS)
248-034-7
Created by admin on Sat Dec 16 09:05:09 GMT 2023 , Edited by admin on Sat Dec 16 09:05:09 GMT 2023
PRIMARY
RS_ITEM_NUM
1667381
Created by admin on Sat Dec 16 09:05:09 GMT 2023 , Edited by admin on Sat Dec 16 09:05:09 GMT 2023
PRIMARY
EVMPD
SUB04876MIG
Created by admin on Sat Dec 16 09:05:09 GMT 2023 , Edited by admin on Sat Dec 16 09:05:09 GMT 2023
PRIMARY